Ebstein畸形的治疗策略:三十年观察性研究
该单中心回顾性研究比较了2012年前后采用个体化手术策略(含Cone修复)治疗Ebstein畸形的长期结局。2012年后患者更年轻且更多接受Cone修复±双向Glenn(BDG),五年生存率从81.7%逐步升至98.5%,2012年前后生存差异显著(P=0.0094)。Carpentier分型高于B型及术后30天内脓毒症是死亡危险因素,BDG与较低风险相关,Cone修复本身不增加死亡风险。
要点
- 2012年后采用个体化策略(更早干预、Cone修复±BDG),五年生存率显著改善至98.5%。
- Carpentier分型高于B型及术后30天内脓毒症是死亡危险因素。
- Cone修复本身不增加死亡风险,BDG与较低死亡风险相关。
核心结论
- 以更早干预为导向、包含Cone修复伴或不伴BDG的个体化策略与生存改善相关。
- 应依据解剖和血流动力学状态制定个体化手术策略。
研究设计与样本
- 回顾性单中心分析,纳入1988年至2022年因Ebstein畸形接受手术的患者。
- 筛查162例,纳入141例,中位年龄14岁(IQR 5-33岁);2012年前手术74例,2012年后67例。
- 采用Kaplan-Meier估计生存,计算限制性平均生存时间(RMST),并用Cox比例风险回归(LASSO变量选择)建模。
主要发现
- 2012年后手术患者更年轻(中位7岁,IQR 1-14 vs 22岁,IQR 14-44;P < 0.001),更多接受Cone修复±BDG。
- 五年生存率逐步改善:2000年1月前81.7%(95% CI 63.7%-91.3%),2000年1月至2012年8月90%(95% CI 75.4%-96.1%),2012年8月后98.5%(95% CI 89.9%-99.8%)。
- 2012年前后生存差异显著(RMST-based log-rank检验 P = 0.0094)。
- Cox回归显示Carpentier分型高于B型(HR 6.19;95% CI 1.69-22.68;P = 0.006)和术后30天内脓毒症(HR 7.75;95% CI 2.09-28.75;P = 0.002)是死亡危险因素。
- Cone修复本身与死亡风险增加无关(HR 1.01;95% CI 0.11-9.57;P = 0.991),BDG与较低风险相关(HR 0.11;95% CI 0.01-0.92;P = 0.041)。
临床怎么用
- 对Ebstein畸形患者可考虑更早干预以保护右心室功能,避免严重恶化后再手术。
- 根据解剖分型和血流动力学状态个体化选择Cone修复及是否联合BDG。
- 重视Carpentier分型高于B型及术后30天内脓毒症的死亡风险。
局限性
- 回顾性单中心设计,样本量有限(141例)。
- 跨三个十年,围术期管理和患者选择可能随时间变化。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study compared long-term outcomes of surgical management for Ebstein's anomaly before and after the introduction of an individualized surgical approach at our centre, including Cone repair. METHODS: We conducted a retrospective, single-centre analysis of patients who underwent surgery for Ebstein's anomaly between 1988 and 2022. Since 2012, early intervention to preserve right ventricular (RV) function before severe deterioration was prioritized. Survival was characterized using Kaplan-Meier estimates, and restricted mean survival time (RMST) was computed up to a specified time horizon. Covariate-adjusted hazard ratios (HRs) were modelled using Cox proportional hazards regression with LASSO-based variable selection. RESULTS: Out of 162 patients screened, 141 (median age: 14 years; IQR: 5-33 years) were included; 74 underwent surgery before 2012 and 67 after. Patients operated after 2012 were younger (median 7, IQR 1-14 vs 22, IQR 14-44 years; P < 0.001) and more frequently received Cone repair, either alone or combined with a bidirectional Glenn procedure (BDG). Five-year survival improved progressively over the analysed periods: from 81.7% (95% CI: 63.7%-91.3%) before January 2000, to 90% (95% CI: 75.4%-96.1%) between January 2000 and August 2012, reaching 98.5% (95% CI: 89.9%-99.8%) after August 2012. The survival difference before and after 2012 was significant (RMST-based log-rank test: P = 0.0094). Cox regression identified Carpentier classification above type B (HR: 6.19; 95% CI: 1.69-22.68; P = 0.006) and postoperative sepsis within 30 days (HR: 7.75; 95% CI: 2.09-28.75; P = 0.002) as risk factors for increased mortality. Cone repair itself was not associated with increased mortality (HR: 1.01; 95% CI: 0.11-9.57; P = 0.991), whereas BDG was associated with a lower hazard (HR: 0.11; 95% CI: 0.01-0.92; P = 0.041). CONCLUSIONS: An individualized strategy that favoured earlier intervention, including Cone repair with or without BDG, was associated with improved survival. These findings highlight the importance of tailoring surgical strategies to anatomical and haemodynamic status in Ebstein's anomaly.
引用
- Murin P, Lorenzen V, Romanchenko O, et al. Treatment Strategies in Ebstein's Anomaly: An Observational Study Over Three Decades. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 41414038. doi:10.1093/icvts/ivaf306
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。